An analysis of IL-36 signature genes and individuals with IL1RL2 knockout mutations validates IL-36 as a psoriasis therapeutic target.
about
Epidermal cornification is preceded by the expression of a keratinocyte-specific set of pyroptosis-related genes.Suppressing IL-36-driven inflammation using peptide pseudosubstrates for neutrophil proteases.The Genetic Basis of Psoriasis.A cytokine network involving IL-36γ, IL-23, and IL-22 promotes antimicrobial defense and recovery from intestinal barrier damage.Interleukin 23 in the skin: role in psoriasis pathogenesis and selective interleukin 23 blockade as treatment.IL-38 has an anti-inflammatory action in psoriasis and its expression correlates with disease severity and therapeutic response to anti-IL-17A treatment
P2860
An analysis of IL-36 signature genes and individuals with IL1RL2 knockout mutations validates IL-36 as a psoriasis therapeutic target.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh
2017年學術文章
@zh-hant
name
An analysis of IL-36 signature ...... psoriasis therapeutic target.
@en
An analysis of IL-36 signature ...... psoriasis therapeutic target.
@en-gb
An analysis of IL-36 signature ...... psoriasis therapeutic target.
@nl
type
label
An analysis of IL-36 signature ...... psoriasis therapeutic target.
@en
An analysis of IL-36 signature ...... psoriasis therapeutic target.
@en-gb
An analysis of IL-36 signature ...... psoriasis therapeutic target.
@nl
prefLabel
An analysis of IL-36 signature ...... psoriasis therapeutic target.
@en
An analysis of IL-36 signature ...... psoriasis therapeutic target.
@en-gb
An analysis of IL-36 signature ...... psoriasis therapeutic target.
@nl
P2860
P50
P1154
2-s2.0-85038417264
P1476
An analysis of IL-36 signature ...... a psoriasis therapeutic target
@en
P2093
Marika Catapano
P2860
P356
10.1126/SCITRANSLMED.AAN2514
P407
P50
P5530
P577
2017-10-01T00:00:00Z
P6179
1092172961